| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An investigation into any correlation between Single Nucleotide Polymorphism (SNP) score and Welsh score in Familial Hypercholesterolaemia patients and those with polygenic hypercholesterolaemia
|
Webster, J.
|
|
|
49 |
S1 |
p. S11-S12
|
artikel
|
| 2 |
An outreaching lipid clinic model supporting PCSK9i uptake and lipid optimisation in secondary prevention across primary/secondary care interface
|
Tucker, C.
|
|
|
49 |
S1 |
p. S11
|
artikel
|
| 3 |
A pharmacist-led remote model for identification and optimisation of Familial Hypercholesterolaemia patients in primary care
|
Scott, C.
|
|
|
49 |
S1 |
p. S10-S11
|
artikel
|
| 4 |
A primary Care based Familial Hypercholesterolaemia screening service in Guernsey, from concept to delivery
|
Dorrian, M.
|
|
|
49 |
S1 |
p. S9
|
artikel
|
| 5 |
Assessment of GENinCode in the Diagnosis of Patients with Suspected Familial Hypercholesterolaemia
|
Carey, P.E.
|
|
|
49 |
S1 |
p. S8-S9
|
artikel
|
| 6 |
Cardiovascular disease morbidity is associated with social deprivation in subjects with familial hypercholesterolaemia (FH): a study comparing FH individuals in UK primary care and the UK Simon Broome register linked with secondary care records
|
Iyen, B.
|
|
|
49 |
S1 |
p. S4-S5
|
artikel
|
| 7 |
Development of a novel secondary care lipid e-referral pathway within Gloucestershire Hospitals NHS Foundation Trust
|
Beale, K.
|
|
|
49 |
S1 |
p. S8
|
artikel
|
| 8 |
Effect of SLCO1B1 genotypes on statin intolerance and response
|
Ghelani, R.
|
|
|
49 |
S1 |
p. S9-S10
|
artikel
|
| 9 |
Familial Hypercholesterolaemia – a targeted Next Generation Sequencing panel and retrospective analysis of patients with no previously identified pathogenic variant
|
Willis, E.
|
|
|
49 |
S1 |
p. S6
|
artikel
|
| 10 |
How many homozygous Familial Hypercholesterolaemia (FH) patients are there likely to be in the UK? : The FH phenotype caused by the APOB p.(Arg3527Trp) variant in a South Asian family
|
Tracey, I.
|
|
|
49 |
S1 |
p. S11
|
artikel
|
| 11 |
How should high cholesterol, mutation negative children, identified through the child-parent screening project be managed?
|
Priestley-Barnham, L.
|
|
|
49 |
S1 |
p. S6-S7
|
artikel
|
| 12 |
I used to dream that my cholesterol could be in single figures, and now it is!!!
|
Pottle, A.
|
|
|
49 |
S1 |
p. S10
|
artikel
|
| 13 |
Lipoprotein (a) – Current status in the UK
|
Ansari, S.
|
|
|
49 |
S1 |
p. S2
|
artikel
|
| 14 |
Lipoprotein apheresis reduces SARS-CoV-2 S protein antibody levels in patients with familial hypercholesterolaemia after vaccination with BNT162b2
|
Valaiyapathi, R.
|
|
|
49 |
S1 |
p. S3-S4
|
artikel
|
| 15 |
Lomitapide in the long-term real-world management of HoFH – effectiveness, tolerability, and hepatic safety from the Pan-European study
|
Cegla, J.
|
|
|
49 |
S1 |
p. S2-S3
|
artikel
|
| 16 |
Low carbohydrate ketogenic diets as a cause of markedly elevated low-density lipoprotein cholesterol
|
Hancox, L.
|
|
|
49 |
S1 |
p. S10
|
artikel
|
| 17 |
Low-density lipoprotein receptor-negative compound heterozygous familial hypercholesterolaemia: case study with follow-up over 23 years
|
van Heyningen, C.
|
|
|
49 |
S1 |
p. S4
|
artikel
|
| 18 |
Modelling a two-stage screen for autosomal dominant familial hypercholesterolaemia (FH) in UK Biobank
|
Gratton, J.
|
|
|
49 |
S1 |
p. S5
|
artikel
|
| 19 |
Posttranscriptional regulation of the LDL Receptor in humans by the U2-spliceosome and its interactors
|
Futema, M.
|
|
|
49 |
S1 |
p. S3
|
artikel
|
| 20 |
The effect of adjusting LDL-cholesterol for Lipoprotein(a)-cholesterol on the diagnosis of Familial Hypercholesterolaemia
|
Thayabaran, D.
|
|
|
49 |
S1 |
p. S3
|
artikel
|
| 21 |
The potential cost-effectiveness of screening algorithms for familial hypercholesterolemia in primary care
|
Jones, M.
|
|
|
49 |
S1 |
p. S6
|
artikel
|
| 22 |
Title Page
|
|
|
|
49 |
S1 |
p. S1
|
artikel
|
Tijdschrift beschrijving